Run a prompt injection attack against Claude Opus 4.6 in a constrained coding environment, and it fails every time, 0% success rate across 200 attempts, no safeguards needed. Move that same attack to ...

NORTH CAROLINA, USA — They’re easy to access, widely promoted online, and backed by doctors. GLP-1 weight-loss injections are proven to help people shed significant weight. But as demand explodes, so ...

Leslie Gammons had used a GLP-1 before, but this time things went wrong. Her online doctor increased the dosage and Gammons ended up in the ER after an overdose. Supreme Court gives Trump — and the ...

Ahead of this week's Opening Ceremony at the Winter Olympics in Milan, the World Anti-Doping Agency has addressed claims originating from a German tabloid that male skiers could be injecting ...

Many people living with rheumatoid arthritis (RA) rely on long-term medications to manage joint pain, stiffness, and inflammation. A number of these treatments are given as subcutaneous injections, ...

VESPER-3 reinforces confidence in monthly dosing of PF-08653944 (MET-097i), including the potential for higher dosing regimens in Phase 3 Study met primary endpoint of statistically significant weight ...

Top executives from drugmakers big and small told CNBC that the next phase of the obesity drug market will be defined by a broader range of treatment options and improved access for patients. CNBC ...

Artificial-intelligence companies have promised that 2026 will be the year of agents: Software that can use AI language models to autonomously execute a complex series of tasks from simple ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at UCL and Moorfields Eye ...